HPV16 infection regulates RASSF1A transcription mediated by p53.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Medicine Reports

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2013.1529PMID 23779024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiproliferative property of n-hexane and chloroform extracts of Anisomeles malabarica (L). R. Br. in HPV16-positive human cervical cancer cells

  2012cited by this paper
• Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells

  2012cited by this paper
• Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation

  2011cited by this paper
• Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.

  2009cited by this paper
• Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation

  2007cited by this paper
• Human papillomavirus: E6 and E7 oncogenes.

  2007cited by this paper
• Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt

  2006cited by this paper
• Molecular biology of human papillomavirus infection and cervical cancer.

  2006cited by this paper
• The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.

  2005cited by this paper
• Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter.

  2005cited by this paper
• Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status.

  2004cited by this paper
• Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis

  2004cited by this paper
• The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• The Scaffold Protein CNK1 Interacts with the Tumor Suppressor RASSF1A and Augments RASSF1A-induced Cell Death*

  2004cited by this paper
• Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.

  2003cited by this paper
• The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

  2003cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002cited by this paper
• The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.

  2002cited by this paper
• The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation

  2002cited by this paper
• Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.

  2002cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• High risk HPV and p53 protein expression in cervical intraepithelial neoplasia

  2000cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• Aberrant p53 protein expression in cervical intra‐epithelial neoplasia

  1993cited by this paper
• A Elicits Apoptosis through an MST 2 Pathway Directing Proapoptotic Transcription by the p 73 Tumor Suppressor Protein

  year unknowncited by this paper

• HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1

  2022cites this paper
• RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy

  2020cites this paper
• Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer

  2020cites this paper
• The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth.

  2017cites this paper
• The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth

  2017cites this paper